Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses

被引:145
作者
Coates, MS
Chan, HK [1 ]
Fletcher, DF
Raper, JA
机构
[1] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[2] Univ Sydney, Dept Chem Engn, Sydney, NSW 2006, Australia
[3] Univ Missouri, Dept Chem Engn, Rolla, MO 65401 USA
基金
澳大利亚研究理事会;
关键词
CFD; computational fluid dynamics; DPI; dry powder aerosols; inhalation drug delivery;
D O I
10.1007/s11095-005-6155-x
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Purpose. The aims of the study are to analyze the influence of air flow on the overall performance of a dry powder inhaler (Aerolizer(R)) and to provide an initial quantification of the flow turbulence levels and particle impaction velocities that maximized the inhaler dispersion performance. Methods. Computational fluid dynamics (CFD) analysis of the flowfield in the Aerolizer(R), in conjunction with experimental dispersions of mannitol powder using a multistage liquid impinger, was used to determine how the inhaler dispersion performance varied as the device flow rate was increased. Results. Both the powder dispersion and throat deposition were increased with air flow. The capsule retention was decreased with flow, whereas the device retention first increased then decreased with flow. The optimal inhaler performance was found at 65 l min(-1) showing a high fine particle fraction (FPF) of 63 wt.% with low throat deposition (9.0 wt.%) and capsule retention (4.3 wt.%). Computational fluid dynamics analysis showed that at the critical flow rate of 65 l min(-1), the volume-averaged integral scale strain rate (ISSR) was 5,400 s(-1), and the average particle impaction velocities were 12.7 and 19.0 m s(-1) at the inhaler base and grid, respectively. Correlations between the device flow rate and (a) the amount of throat deposition and (b) the capsule emptying times were also developed. Conclusions. The use of CFD has provided further insight into the effect of air flow on the performance of the Aerolizer(R). The approach of using CFD coupled with powder dispersion is readily applicable to other dry powder inhalers (DPIs) to help better understand their performance optimization.
引用
收藏
页码:1445 / 1453
页数:9
相关论文
共 32 条
[1]
Use of aerosols for bronchial provocation testing in the laboratory: Where we have been and where we are going [J].
Anderson, SD ;
Brannan, JD ;
Chan, HK .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2002, 15 (03) :313-324
[2]
Calibration at different flow rates of a multistage liquid impinger [J].
Asking, L ;
Olsson, B .
AEROSOL SCIENCE AND TECHNOLOGY, 1997, 27 (01) :39-49
[3]
The cohesive-adhesive balances in dry powder inhaler formulations I: Direct quantification by atomic force microscopy [J].
Begat, P ;
Morton, DAV ;
Staniforth, JN ;
Price, R .
PHARMACEUTICAL RESEARCH, 2004, 21 (09) :1591-1597
[4]
Borgström L, 2002, LUNG BIOL HEALTH DIS, V162, P421
[5]
Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol [J].
Brannan, JD ;
Anderson, SD ;
Gomes, K ;
King, GG ;
Chan, HK ;
Seale, JP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (06) :1420-1425
[6]
*BRIT PHARM, 2001, AER ASS FIN PART FIN
[7]
Chavan V, 2002, AAPS PHARMSCI, V4
[8]
Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols [J].
Chew, NYK ;
Chan, HK .
PHARMACEUTICAL RESEARCH, 1999, 16 (07) :1098-1103
[9]
Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders [J].
Chew, NYK ;
Bagster, DF ;
Chan, HK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 206 (1-2) :75-83
[10]
In vitro aerosol performance and dose uniformity between the Foradile® Aerolizer® and the Oxis® Turbuhaler® [J].
Chew, NYK ;
Chan, HK .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2001, 14 (04) :495-501